Tue, 03rd Apr 2018 16:19
The pharmaceutical company said it made an application to AIM for the admission of 1.6 million VCT shares occuring early on Wednesday. It also requested to place 3.9 million shares and 3.2 million convertible loan shares on Thursday.
Diurnal said it will have 54.2 million shares after VCT shares admission and 61.3 million shares following both admissions.
The stock was trading 1.5% lower at
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:
(Alliance News) - Diurnal Group PLC on Friday said its Efmody treatment has been recommended as an option to treat patients with congenital adrenal hy...
(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced on Friday that the All-Wales Medicines Strategy Group (AWMSG) has recommen...